Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1654 1675
This examiner grants 76% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19369023 | ANTI-ISCHEMIC COMPOSITIONS | Non-Final OA | SERAPHIM THERAPEUTICS, INC. |
| 18017041 | CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY | Non-Final OA | Novo Nordisk A/S |
| 17598010 | GLUCOSE SENSITIVE INSULIN DERIVATIVES | Non-Final OA | Novo Nordisk A/S |
| 17908825 | ANTIVIRAL STRUCTURALLY-STABILIZED SARS-CoV-2 PEPTIDES AND USES THEREOF | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 18012288 | METHOD AND COMPOSITION FOR REDUCING OR PREVENTING BONE RESORPTION | Non-Final OA | University of Connecticut |
| 17916170 | CASPASE INHIBITORS TO ENHANCE INJURY REPAIR AND TO TREAT BACTERIAL AND VIRAL INFECTIONS | Non-Final OA | The Johns Hopkins University |
| 18011363 | COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING COGNITIVE DYSFUNCTION DISEASE, COMPRISING PEPTIDE HAVING SYNAPTIC PLASTICITY CONTROL FUNCTION | Non-Final OA | UIF (University Industry Foundation), Yonsei University |
| 17755939 | USE OF ALPHA-LACTALBUMIN ENRICHED WHEY PROTEIN EXTRACT AS A SOURCE OF CHOLESTEROL | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18174158 | METHODS, SYSTEMS, AND COMPOSITIONS FOR LEGUME-BASED PRODUCTION OF THERAPEUTIC PROTEINS AND THERAPEUTIC MEDICAL MATERIALS | Non-Final OA | Arizona Board of Regents on Behalf of The University of Arizona |
| 18652429 | TUMOR ASSOCIATED MONOCYTE/MACROPHAGE BINDING PEPTIDE AND METHODS OF USE THEREOF | Non-Final OA | Sanford Burnham Prebys Medical Discovery Institute |
| 17759634 | ALLERGEN PROTECTION FOR THE SKIN | Non-Final OA | BEIERSDORF AG |
| 17908015 | Undenatured Type II Collagen in Food and Beverage Applications and Uses Thereof | Final Rejection | Lonza Greenwood LLC |
| 17908532 | COMPOUNDS FOR USE IN AUTOIMMUNE CONDITIONS | Non-Final OA | PHARMA MAR, S.A. |
| 17963739 | METHOD FOR PREPARING LIRAGLUTIDE USING ENVIRONMENT-FRIENDLY SOLVENT | Non-Final OA | DAEBONG LS CO., LTD. |
| 17299795 | VASODILATORS FOR USE IN THE TREATMENT OF A RETINAL ISCHEMIC DISORDER | Non-Final OA | Rigshospitalet |
| 18037463 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | Non-Final OA | THE BOOTS COMPANY PLC |
| 18022739 | ANTIMICROBIAL PEPTIDE OR PEPTIDE DERIVATIVE, SUBSTITUTE, AND COMPOSITION THEREOF, AND PREPARATION METHOD AND APPLICATION OF COMPOSITION | Final Rejection | QC BIO-TECHNOLOGY (SHENZHEN) CO., LTD. |
| 17922487 | METHODS OF TREATMENT COMPRISING STABLE REDUCED GLUTATHIONE | Non-Final OA | Professional Nutraceutical Design, LLC |
| 17917858 | COMPOSITIONS AND USES OF LOCALLY APPLIED SYNTHETIC AMINO ACID POLYMERS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS | Non-Final OA | Amicrobe, Inc. |
| 17912247 | COMPOSITIONS HAVING MULTIPLE RECOMBINANT HUMAN GROWTH FACTORS INCLUDED THEREIN FOR REDUCING SIGNS OF AGING | Non-Final OA | SkinGen international Inc. |
| 17906003 | USE OF ANTI-AGING GLYCOPEPTIDES FOR TREATMENT OF DRY EYE DISEASE, RETINAL DEGENERATIVE DISEASES, OR OCCULAR INFLAMMATION | Non-Final OA | Protokinetix Inc. |
| 17905907 | EFFICIENT PREPARATION OF DOLASTATIN AND AURISTATIN ANALOGS THROUGH A COMMON INTERMEDIATE | Non-Final OA | Sigma-Aldrich Co. LLC |
| 17857797 | TREATMENT OF NEURODEGENERATIVE PROTEINOPATHIES USING FAS APOPTOSIS INHIBITORY MOLECULE (FAIM) OR A FRAGMENT AND/OR A MIMETIC THEREOF | Final Rejection | Thomas L. ROTHSTEIN |
| 17441130 | FUSION PROTEIN CONTAINING FLUORESCENT PROTEIN FRAGMENTS AND USES THEREOF | Final Rejection | NINGBO KUNPENG BIOTECH CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy